Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs
GeekWire
DECEMBER 27, 2022
Everyone is budgeting 50% longer to raise their rounds,” said Canestaro. In Washington, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology all shed employees in 2022. Sonoma chief technology officer Heidi Hagen. Sonoma Photo). Phage Genomics CEO Ivan Liachko.
Let's personalize your content